Clinical Trials Browser

INDUSTRY × Lymphangioleiomyomatosis × Everolimus × Clear all

NCT03525834 2021-09-09

Safety and Efficacy of Everolimus (Afinitor®) in Chinese Adult Patients With Angiomyolipoma Associated With Tuberous Sclerosis Complex.

Phase 4 Completed

40 enrolled 10 charts

Tuberous Sclerosis, Lymphangioleiomyomatosis, Angiomyolipoma

NCT01059318 2020-11-19

A Study to Determine the Safety and Effectiveness of RAD001 (Everolimus) in Patients With Lymphangioleiomyomatosis

Phase 2 Completed

24 enrolled 13 charts

Lymphangioleiomyomatosis